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S-glutathionylation of IRF3 regulates IRF3–CBP
interaction and activation of the IFNb pathway
Efthimios Prinarakis1, Eleni Chantzoura1,
Dimitris Thanos2 and Giannis Spyrou1,*
1Center of Basic Research I—Biochemistry Division, Biomedical
Research Foundation, Academy of Athens, Athens, Greece and
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Interferon regulatory factor 3 (IRF3) is an essential tran-
scriptional regulator of the interferon genes. IRF3 is con-
stitutively present in a latent conformation in the cell
cytoplasm. In cells infected by Sendai virus, IRF3 becomes
phosphorylated, homodimerizes, translocates to the nu-
cleus, binds to target genes and activates transcription by
interacting with CBP/p300 co-activators. In this study, we
report that in non-infected cells IRF3 is post-translation-
ally modified by S-glutathionylation. Upon viral-infection,
it undergoes a deglutathionylation step that is controlled
by the cytoplasmic enzyme glutaredoxin-1 (GRX-1). In
virus-infected GRX-1 knockdown cells, phosphorylation,
homodimerization and nuclear translocation of IRF3 were
not affected, but the transcriptional activity of IRF3
and the expression of interferon-b (IFNb), were severely
reduced. We show that deglutathionylation of IRF3 is
necessary for efficient interaction of IRF3 with CBP, an
event essential for transcriptional activation of the inter-
feron genes. Taken together, these findings reveal a crucial
role for S-glutathionylation and GRX-1 in controlling the
activation of IRF3 and IFNb gene expression.
The EMBO Journal (2008) 27, 865–875. doi:10.1038/
emboj.2008.28; Published online 28 February 2008
Subject Categories: proteins; immunology
Keywords: glutaredoxin; interferon beta; IRF3; S-glutathio-
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Introduction
Reactive oxygen species (ROS) such as hydrogen peroxide
(H2O2) are formed and degraded by all aerobic organisms.
Generation of excessive amounts of ROS into cells, called
oxidative stress, alters their oxidant/redox status. Although
ROS, in general, damage macromolecules including DNA and
proteins, they can also function as regulators or secondary
messengers of intracellular signal transduction pathways
(Thannickal and Fanburg, 2000). Among the most susceptible
oxidant-sensitive targets are thiol groups on proteins that can
be reversibly oxidized to sulphenic acid (-SOH). Reversible
oxidation is considered to be a homeostatic mechanism that
protects proteins from irreversible oxidation (Thomas et al,
1995) and also constitutes a critical post-translational
modification mechanism that can regulate or alter protein
function (Cotgreave and Gerdes, 1998; Klatt and Lamas,
2000). The sulphenic acid moiety is very unstable and readily
reacts with other thiols to form intra- or intermolecular
disulphides. Reaction with glutathione (GSH) results in the
formation of mixed disulphides with GSH known as S-glu-
tathionylation (protein-SSG formation). This modification
has been shown to be essential for the function of several
proteins such as NF1, c-jun, p50/NF-kB, actin and IkB kinase
subunit b (IKKb) (Bandyopadhyay et al, 1998; Klatt et al,
1999; Pineda-Molina et al, 2001; Wang et al, 2001; Reynaert
et al, 2006). Glutaredoxin-1 (GRX-1) is a cytoplasmic enzyme
that catalyzes the reversible reduction of the protein-glu-
tathionyl-mixed disulphides to free sulphhydryl groups
through a monothiol mechanism (Gravina and Mieyal,
1993; Yang et al, 1998). During this process, GRX-1 becomes
S-glutathionylated at Cys-23 of its conserved catalytical motif
Cys-X-X-Cys. Reduction of GRX-1–SSG is accomplished by
GSH and glutathione disulphide reductase at the expense
of NADPH to NADP transformation (Yang et al, 1998). As
mammalian GRX-1 functions in a substrate-specific manner
towards S-glutathionylated proteins (Gravina and Mieyal,
1993; Fernandes and Holmgren, 2004) and because some of
them are crucial components of many signalling pathways,
GRX-1 is believed to have an important function in signal
transduction (Ghezzi, 2005; Shelton et al, 2005).
Interferons (IFNs) are cytokines involved in diverse biolo-
gical functions including antiviral response, inhibition of
proliferation, induction of differentiation, modulation of im-
mune system and inhibition of angiogenenesis (Uddin and
Platanias, 2004). Initially, IFNs were discovered through their
anti-viral activities. Type I IFNs (IFNa and IFNb) are pro-
duced by virus-infected host cells and constitute the primary
response against virus infection. All IFNs bind to specific
receptors present on the cell surface and by doing so activate
the JAK–STAT signalling pathway eliciting their effects
through the transcriptional activation of target genes bearing
specific DNA-binding recognition sites (ISREs) within their
promoters (Darnell et al, 1994; Ihle, 1996; Stark et al, 1998).
Rapid induction of type I IFNs following virus infection
requires post-translational modification of latent transcrip-
tion factors involved in immunomodulation, including
NF-kB, ATF-2/c-Jun and interferon regulatory factor 3
(IRF3) (Thanos and Maniatis, 1995a, b; Juang et al, 1998;
Sato et al, 2000). IRF3 is a 55 kD protein constitutively
expressed in a variety of tissues and maintained in a latent
conformation in the cytoplasm (Nguyen et al, 1997). Virus-
induced C-terminal phosphorylation of IRF3 represents a key
post-translational modification, leading to dimerization,
cytoplasmic-to-nuclear translocation, association with CBP/
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p300 co-activators, binding to ISREs of target genes, including
the PRDIII-I regions of the IFNb gene promoter, and transcrip-
tional activation (Fujita et al, 1988; Miyamoto et al, 1988; Lin
et al, 1998; Sato et al, 1998; Weaver et al, 1998; Yoneyama
et al, 1998).
In this study, we investigated the role of GRX-1 in the
signal transduction pathways leading to IFNb production in
virus-infected cells. Our data demonstrated that, in GRX-1
knockdown (KD) cells infected with Sendai virus, the expres-
sion of IFNb was significantly reduced, suggesting a critical
role for GRX-1 in the IFNb gene activation pathway. More
specifically, we found that GRX-1 was essential for the
transcriptional activity of IRF3. We showed that IRF3 is
S-glutathionylated in non-infected cells, but upon viral in-
duction, IRF3 undergoes deglutathionylation catalyzed by
GRX-1. Our experiments revealed that, in GRX-1 KD cells,
phosphorylation, dimerization and nuclear translocation
of IRF3 were not altered, but its transactivation ability
was reduced due to the inefficient recruitment of the CBP
transcription co-activator. Collectively, this study uncovered
an essential role for GRX-1 in the IRF3 activation and the
signalling regulation of the IFNb pathway. Our work also
underscores the role of S-glutathionylation as a crucial
post-translational modification that is able to regulate
signalling pathways.
Results
GRX-1 is essential for the IRF activation and IFN b
production
To study the role of GRX-1 on the IFNb pathway activation,
we generated a HEK293 stable cell line that underexpresses
GRX-1 due to RNA interference, namely TGi14, and a control
cell line, TV7, transfected with the empty vector. GRX-1
mRNA levels in TGi14 and TV7 cells were estimated by
quantitative real-time PCR. TGi14 cells showed a 71% reduc-
tion of GRX-1 mRNA compared with control cells (Figure 1A).
The RNAi specificity for GRX-1 was confirmed by real-time
PCR for GRX-2, another glutaredoxin located in mitochondria
(Figure 1A). The endogenous GRX-1 protein levels in TV7
cells were below the detection limit for the two different anti-
GRX-1 antibodies used; thus we analysed the protein levels of
GRX-1 in TV7 and TGi14 cells co-transfected with pIRES–
GRX-1 and a DRF–TRAF6 expression plasmid as transfection
efficiency marker. GRX-1 was reduced in TGi14 cells com-
pared with TV7 cells (Figure 1B). Reduction of the GRX-1
levels did not affect the glutathione concentration in TGi14
cells compared to the control cell line (Figure 1C).
To investigate whether GRX-1 was involved in the IFNb
gene activation pathway, TV7 and TGi14 cells were trans-
fected with either PRDIII–I3-luc (12 IRF-binding sites) or
110-luc (IFNb promoter) reporter plasmids and 18 h later
were infected with Sendai virus for 9 h. As shown in
Figure 2A (compare lanes 2 and 4), reduction of the GRX1
levels resulted in a strong decrease of IRF-dependant activa-
tion after viral infection. These results suggest that GRX-1 is
required for IRF-dependant transcription upon viral infection.
Moreover, GRX-1 underexpression resulted in almost 60%
lower activation of the entire IFNb promoter upon viral
infection (Figure 2B). We have also analysed the effect of
GRX-1 underexpression on NF-kB activation, using the
PRDII4-luc (four NF-kB-binding sites) reporter plasmid, as
well as the IL-8 promoter. Both IL-8 and -110 promoters
contain NF-kB- and AP-1-binding sites, but the IL-8 promoter
has a C/EBP-binding site instead of IRF-binding sites. NF-kB
activation in virally induced TGi14 cells was slightly affected
(Figure 2C), whereas there was almost no effect on the
activation of the IL-8 promoter (Figure 2D). These results
suggest that GRX-1 primarily affects the IRF-dependant tran-
scription activation pathways. Similar results were also ob-
tained by the respective transfection experiments in a HeLa
stable cell line that underexpresses GRX-1 (HGR7) and a
control cell line (HV7) (Supplementary Figure S2 and S3).
To examine whether restoration of GRX-1 in TGi14 cells
could reverse the loss of IRF activation, TV7 and TGi14 cells
were co-transfected with PRDIII–I3-luc reporter along with
empty vector or pIRES-GRX-1 and infected with Sendai
virus as described above. As shown in Figure 3, control
cells transfected with GRX-1 and infected with Sendai virus
could activate transcription more efficiently when compared
with cells infected only with virus indicating synergistic
interactions (compare bars 2, 3 and 4). GRX-1 expression in
TGi14 cells resulted in restoration of IRF activation upon viral
induction, reaching levels similar to control cells transfected
with empty vector and infected with virus (compare bars 2
and 8).
To estimate the physiological impulse of GRX-1 to the anti-
viral response, TV7 and TGi14 cells were infected with Sendai
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Figure 1 (A) RNAi-mediated knockdown of GRX-1. Real-time PCR
was performed in cDNA from TV7 and TGi14 cells to estimate the
mRNA levels of GRX-1 (left panel) and GRX-2 (right panel). Values
have been corrected by the respective values of GAPDH mRNA for
each sample. Mean values from three independent experiments are
presented. (B) TV7 and TGi14 cells were transfected with 0.5 mg of
pIRES-GRX-1 along with 0.5mg cDNA3 Flag–DRF–TRAF6 as marker
for transfection efficiency. Whole-cell extracts were separated on
SDS gel and blotted with antibodies to GRX-1, Flag epitope and
b-actin as loading control. (C) Glutathione concentration was
measured in TV7 and TGi14 cells. Average values from three
independent experiments, expressed as nmol ml1 of cell extracts,
are presented.
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virus, and after 9 h, total RNA was isolated and used for
cDNA production in reverse transcriptase (RT) reaction.
cDNA was used as template in semi-quantitative PCR assay
for IFNb and GAPDH as control (Figure 4A). Quantitative
real-time PCR for IFNb and IL-8 was also performed
(Figure 4B). Both analysis showed that in TGi14 cells the
transcription of IFNb gene upon viral induction was dimin-
ished, whereas IL-8 production was not affected, indicating a
key role for GRX-1 in the primary anti-viral response of the cells.
IRF3 is S-glutathionylated and GRX-1 is needed for its
deglutathionylation upon viral infection
GRX-1 is a constitutively active cytoplasmic enzyme, known
to control S-glutathionylation of target proteins (Gravina and
Mieyal, 1993; Yang et al, 1998). As IRF3 is a transcription
factor located in a latent form in the cytoplasm of uninfected
cells (Nguyen et al, 1997), we tested whether IRF3 was
S-glutathionylated and whether GRX-1 controlled this
modification. TV7 cells were either mock- or virus-infected
for 9 h or cultured in the presence of 200 mM L-buthionine-
(S,R)-sulphoximine (BSO) (an inhibitor of GSH synthesis)
(Anderson, 1997) for 4 days. Cytoplasmic cell extracts were
prepared and used in immunoprecipitation experiments
with anti-IRF3 antibody followed by western blot analysis
using anti-IRF3 and anti-GSH antibodies (Figure 5A). We
found that IRF3 was S-glutathionylated in its inactive
form (lane 1) and its S-glutathionylation was significantly
reduced upon viral infection (lane 2). The amount of IRF3
S-glutathionylation upon viral infection resembles the
one observed in non-infected cells cultured with BSO
(lane 3). Immunoprecipitation with anti-STAT1 antibody
was also performed in cytoplasmic extracts from TV7 cells
either mock-induced or induced with recombinant IFNb,
as control experiment for S-glutathionylation specificity. As
shown in Figure 5B, no S-glutathionylation was observed on
TV7
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Figure 2 Activation of PRDIII-I, PRDII, –110 and IL-8 reporters in
TV7 and TGi14 cell lines. Cells were transfected with the indicated
plasmids (0.3mg per well) and 18 h later were infected with Sendai
virus (SV) for 9 h. (A) activation of the PRDIII–I3-luc; (B) activation
of the -110-luc; (C) activation of the PRDII4–luc; (D) activation of the
IL-8-luc. Luciferase values have been normalized by the respective
b-galactosidase values (0.1mg pGK-b-gal reporter per well co-trans-
fected) in all experiments. Data are expressed as means7s.d. from a
minimum of three independent experiments.
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Figure 3 Activation of PRDIII-I reporter in TV7 and TGi14 cells
transfected with GRX-1 and induced with Sendai virus. Cells were
transfected with PRDIII-I3-luc (0.3mg per well) and GRX-1 (0.4mg
per well) and 18 h later were infected with Sendai virus for 9 h.
Luciferase values have been normalized by b-galactosidase values
(0.1 mg pGK–b-gal reporter per well).
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Figure 4 Underexpression of GRX-1 drastically reduces IFNb gene
transcription upon viral infection. (A) Semi-quantitative RT–PCR
for IFNb expression in TV7 and TGi14 cells mock-induced or
induced with virus for 9 h. Upper panel shows the respective
expression of GAPDH in those cells. (B) Real-time PCR for IFNb
(left panel) and IL-8 (right panel) gene expression, in TV7 and
TGi14 cells infected with virus for 9 h. Both experiments were
normalized with the respective real-time PCR values for GAPDH,
and data are presented as means of % relative mRNA produc-
tion7s.d. from three independent experiments.
Regulation of IRF3 and IFNb pathway by GRX-1
E Prinarakis et al
&2008 European Molecular Biology Organization The EMBO Journal VOL 27 | NO 6 | 2008 867
STAT1 under normal conditions or upon induction with IFNb.
To determine the specificity of IRF3 deglutathionylation upon
virus infection, we analysed the extent of deglutathionylation
of GAPDH, a protein that has been reported to be S-glutathio-
nylated (Lind et al, 1998). GAPDH was immunoprecipitated
from cytoplasmic extracts of TV7 cells either mock-induced
or induced with virus for 9 h and western blotted for GSH. No
difference in the S-glutathionylation of GAPDH was observed
upon viral induction (Figure 5C), suggesting that the effect of
Sendai virus induction on the S-glutathionylation levels of
IRF3 is specific. GRX-1 was responsible for deglutathionyla-
tion of IRF3, as the overall amount of S-glutathionylated IRF3
that became deglutathionylated upon viral infection in TGi14
cells was much less, compared with control cells (Figure 5D).
Next, we analysed the glutathionylation status of IRF3
bound to Bio-ISRE (oligo-binding IRF3) in nuclear extracts
prepared from mock- and virus-infected TV7 cells. Binding of
IRF3 to the Bio-ISRE oligo was observed in nuclear extracts
from virus-infected cells (Figure 5E, compare lanes 4 and 5).
However, no S-glutathionylation was observed in IRF3 when
bound to DNA (lane 2). Immunoprecipitated IRF3 from mock
cytoplasmic extracts of TV7 cells was used as positive control
for S-glutathionylation (Figure 5E, lane 3). These results
suggest that activated IRF3 that can bind DNA is deglutathio-
nylated; however, from these experiments, we cannot con-
clude that glutathionylation affects the DNA binding of IRF3.
GRX-1 underexpression does not affect the dimerization
and nuclear translocation of IRF3
Viral infection activates IRF3 through a biochemical cascade
leading to phosphorylation and subsequent dimerization of
the molecule. The activated IRF3 enters the nucleus, associ-
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Figure 5 IRF3 is S-glutathionylated in its inactive form and its glutathionylation status is altered upon viral infection. (A) IRF3 was
immunoprecipitated from cytoplasmic extracts (300mg) of TV7 control cells either mock-induced or induced with Sendai virus for 9 h or
cultured with 200 mM BSO for 4 days. Proteins were separated on SDS–PAGE and probed with anti-IRF3 and anti-GSH antibodies. (B)
Cytoplasmic extracts (300mg) of TV7 cells either mock-induced or induced with IFNb (500 IU ml1) for 30 min were used for STAT1
immunoprecipitation. Proteins were separated on SDS–PAGE and probed with anti-STAT1 and anti-GSH antibodies. (C) GAPDH was
immunoprecipitated from cytoplasmic extracts (300mg) of TV7 cells either mock-induced or induced with Sendai virus for 9 h. Proteins were
western blotted with anti-GAPDH and anti-GSH antibodies. (D) IRF3 was immunoprecipitated from cytoplasmic extracts (300mg) of TV7 and
TGi14 cells either mock-induced or induced with Sendai virus for 9 h. The proteins were separated on SDS–PAGE and probed with anti-IRF3 and
anti-GSH antibodies. (E) Double-stranded biotinylated-ISRE oligo was bound to magnetic streptavidin beads. Equal amounts of nuclear extracts
(100mg) from TV7 cells mock-induced or induced with virus for 4 h were mixed with Bio-ISRE beads in the presence or absence of mutated ISRE
or wild-type ISRE, incubated at room temperature for 20 min, washed and subjected to SDS–PAGE. The proteins were probed with anti-IRF3 and
anti-GSH antibodies. Immunoprecipitated IRF3 from mock TV7 cytoplasmic extracts was used as positive control (lanes 3 and 9).
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ates with transcription co-activators and promotes transcrip-
tion of target genes (Lin et al, 1998; Sato et al, 1998; Weaver
et al, 1998; Yoneyama et al, 1998). To investigate whether
GRX-1 has an important function in IRF3 dimerization,
whole-cell extracts from TV7 and TGi14 cells, mock-infected
or infected with Sendai virus for 9 h, were prepared. Extracts
were separated in a 7.5% native gel and blotted with anti-
IRF3 antibody (Figure 6A). Underexpression of GRX1 in
TGi14 cells did not alter the formation of the IRF3 homodimer
upon viral induction (compare lanes 2 and 4). Moreover,
nuclear translocation experiments performed in TV7 and
TGi14 cells, transfected with GFP–IRF3 and then infected
with Sendai virus revealed no significant differences in IRF3
translocation between the two cell lines (Figure 6B and C).
GRX-1 is essential for IRF3 ability to promote
transcription
As IRF3 could be activated and translocated in the nucleus
when GRX-1 was underexpressed, we tested whether deglu-
tathionylation was essential for IRF3 to promote transcrip-
tion. We transfected both cell lines with a GAL4-luc reporter
together with the GAL4–IRF3 DN133 construct in which the
IRF3 DNA-binding domain was replaced with the GAL4 DNA-
binding domain, ensuring its binding to the GAL4 luciferase
reporter. Moreover, the construct bears its own nuclear
localization signal (NLS) to guarantee the entry of the factor
into the nucleus. As shown in Figure 7A, upon viral infection,
transcriptional activation of GAL4 luciferase was reduced by
80% in TGi14 cells compared with control cells (lanes 2 and
4), suggesting that GRX-1 underexpression affects the ability
of the factor to promote transcription through its transactiva-
tion domain. To ensure that binding ability of GAL4 con-
structs was not altered by GRX-1 underexpression, we
performed similar experiments using GAL4-VP16, a potent
transcription activator. No significant differences in GAL4-
luciferase reporter activation between TV7 and TGi14 cell
lines were observed (Figure 7B).
Deglutathionylation of IRF3 catalyzed by GRX-1 is
required for IRF3–CBP interaction
IRF3 bears a hydrophobic surface, exposed upon dimer
formation, that recruits CBP/p300 co-activator and functions
as a transactivation domain (Qin et al, 2003). As GRX-1 was
essential for transcriptional activation by IRF3, the possibility
that GRX-1 influences IRF3–CBP interaction was investigated.
To address whether CBP overexpression can restore the loss
of IRF3 transcription activity when GRX-1 is underexpressed,
we conducted the transfection experiments described in
Figure 8. As expected, CBP overexpression improved the
transcriptional activation of all reporters used (GAL4-luc,
PRDIII–I3-luc and –110-luc), but could not restore the
transactivation ability of IRF3 in TGi14 cells (compare
lanes 4 and 8 in A, B and C). These results indicate that
IRF3 could not interact efficiently with CBP when IRF3 was
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Figure 6 GRX-1 underexpression does not affect dimerization and nuclear translocation of IRF3 upon viral infection. (A) Western blot analysis
of IRF3 in TV7 and TGi14 cells either mock-induced or induced with virus for 9 h. Whole-cell extracts (20mg) have been separated on a 7.5%
acrylamide native gel, and the active IRF3 dimer is visible. (B) TV7 and TGi14 cells were transfected with GFP–IRF3 (0.5 mg per well) and mock-
stimulated or stimulated with virus for 16 h. Nuclear translocation of GFP–IRF3 was measured by microscopy observation of 250 living cells in
each well. (C) The percentage of cells with nuclear translocation of GFP–IRF3 induced by virus is shown.
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not deglutathionylated. In contrast, transcriptional activation
of the IL-8 reporter in TGi14 cells was not affected, indicating
that GRX-1 does not alter the ability of CBP to activate
transcription (Figure 8D, compare lanes 4 and 8). To further
investigate the regulatory role of GRX-1 in the IRF3–CBP
interaction, nuclear extracts from TV7 and TGi14 cells in-
duced for 9 h with Sendai virus were prepared, subjected to
immunoprecipitation with anti-CBP antibody and blotted for
CBP and IRF3. As shown in Figure 9A, there was much less
IRF3 co-precipitated with CBP in virus-infected TGi14 cells than
in respective TV7 cells, although the amounts of immuno-
precipitated CBP were similar (compare lanes 6 and 8). These
results showed that GRX-1 was required for efficient interac-
tion of CBP with the activated IRF3 in virus-infected cells. To
confirm the observation that S-glutathionylated IRF3 does not
bind CBP, we treated nuclear extracts from TGi14 cells either
mock- or virus-infected with DTT (a non-specific reducer of
disulphide bonds) or purified hGRX-1 before CBP immuno-
precipitation. As shown in Figure 9B, DTT treatment resulted
in even less co-precipitation of IRF3 with CBP (compare lanes
5 and 6), suggesting that certain disulphide bonds are needed
for efficient interaction between CBP and activated IRF3. In
contrast, after GRX-1 treatment, the co-precipitated IRF3 was
strongly increased in the viral-induced nuclear extracts
(Figure 9C, compare lanes 5 and 6). These results strongly
suggest that deglutathionylation of IRF3 is required for its
efficient interaction with CBP. As control,
we showed that hGRX-1 can deglutathionylate IRF3 under
experimental conditions (Figure 9D).
Discussion
S-glutathionylation is a post-translational modification hav-
ing an important function in the role of several proteins as
well as in the pathways these proteins may be involved in
(Bandyopadhyay et al, 1998; Klatt et al, 1999; Pineda-Molina
et al, 2001; Wang et al, 2001; Reynaert et al, 2006). Our
interest was to investigate a possible role of GRX-1 in the
IFNb pathway. To accomplish this, we generated a stable HEK
293 GRX-1 knockdown cell line, TGi14. According to our
data, TGi14 cells were at least 50% less efficient in supporting
transactivation of the IFNb promoter compared to control
cells, when induced with Sendai virus. This reduction was
specific for the IFNb promoter, as the IL-8 promoter, which
also contains NF-kB- and AP1-binding sites, but a C/EBP site
instead of the IRF-binding sites, was fully active in GRX-1-
underexpressing cells. It was shown recently by Reynaert
et al (2006) that GRX-1 regulates the activation of IKKb upon
TNFa stimulation. Their findings revealed that IKKb is
S-glutathionylated and needs to be deglutathionylated by
GRX-1 to be fully catalytically active. We observed a 25%
loss of the PRDII promoter activation in GRX-1 KD cells,
indicating a small reduction in the NF-kB activation, probably
due to inefficient IKKb activation. This low reduction of NF-
kB activation in the GRX-1 KD cells was also reflected in the
9% reduction of the IL-8 promoter activation observed in
these cells. Strikingly, the PRDIII-I promoter, which binds
IRFs, was 85% less active in GRX-1-underexpressing cells
compared with control cells upon viral induction, suggesting
that fall of the -110 promoter activation in GRX-1 KD cells
was mainly due to the IRF proteins. To demonstrate the
general relevance of our observation, we have repeated
these experiments with similar results using a stable HeLa
GRX-1 knockdown cell line.
The GRX-1 restoration experiments revealed that the de-
creased activation by IRFs was specifically correlated with the
underexpression of GRX-1 in the knockdown cells. An inter-
esting finding was that overexpression of GRX-1 combined
with virus infection in control cells resulted in ‘super’ activa-
tion of PRDIII-I promoter in a synergistic manner, indicating
that GRX-1 may be a limiting factor for the activation of IRF.
However, virus infection had no effect on gene expression of
GRX-1 (data not shown). More importantly, real-time PCR
experiments for IFNb expression showed that GRX-1 under-
expression dramatically reduced the IFNb transcription upon
viral induction, suggesting that GRX-1 is an essential regu-
lator of the IFNb pathway.
It has been previously reported that Sendai virus induces
IRF3 activation (Lin et al, 1998; Yoneyama et al, 1998; Hiscott
et al, 1999) and this activation was independent of both
interferon production and virus replication (Collins et al,
2004). Furthermore, IRF3, but not IRF1, IRF7 or IRF9,
was critical for the initial response to virus particle entry
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Figure 7 GRX-1 affects the ability of IRF3 to promote transcription
through its transactivation domain. (A) Average activation of GAL4-
luc reporter (0.5mg per well) in TV7 and TGi14 cells, co-transfected
with GAL4–IRF3 DN133 (0.2mg per well) and either mock-induced
or induced with virus for 9 h. Luciferase values have been normal-
ized by b-galactosidase values (0.1mg pGK–bgal reporter per well).
(B) Average relative transcriptional activation (%) of GAL4-luc
reporter (0.5mg per well) in TV7 and TGi14 cells transfected with
GAL4-VP16 (0.2 mg per well) either mock-induced or induced with
virus for 9 h. Data are expressed as means7s.d. from a minimum of
three independent experiments.
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(Collins et al, 2004). Therefore, we investigated the pos-
sibility that GRX-1 regulates the IRF3 activation pathway.
Immunoprecipitation experiments revealed that IRF3 is
S-glutathionylated under normal conditions and that GRX-1
is responsible for its deglutathionylation upon viral infection.
Moreover, a DNA-binding assay for IRF3 revealed that the
activated factor binds to DNA in its deglutathionylated form.
Upon virus induction, IRF3 is phosphorylated at its C-term
region, and it dimerizes and enters the nucleus to promote
transcription of specific promoters bearing ISRE-binding ele-
ments. Our data revealed that formation of IRF3 homodimers,
a requirement for the factor’s activation process, was not
altered in GRX-1 KD cells, suggesting that deglutathionylation
of IRF3 is not essential for the phosphorylation and dimer-
ization of the factor in the cytoplasm. In addition, nuclear
translocation of GFP-IRF3 constructs upon viral infection was
not affected by GRX-1 underexpression.
We used the IRF3-GAL4 fusion to determine the transacti-
vation ability of IRF3 upon induction with virus in control
and GRX-1 KD cells. GRX-1 underexpression severely reduced
GAL4-luc activation, indicating that the transactivation abil-
ity of IRF3 is regulated by GRX-1 and that deglutathionylation
is required for its ability to transactivate transcription. CBP/
p300 is an essential co-activator for several transcription
factors and its amount in vivo is not excessive, but rather
limiting (Tanaka et al, 1997). IRF3 interacts with the CBP/
p300 co-activators to initiate transcription (Yoneyama et al,
1998). Our initial hypothesis was that deglutathionylation
of IRF3 may be required for efficient interaction with
CBP. Overexpression of CBP in cells raised the transcriptional
activity of IRF3, but failed to restore the loss of transcriptional
activity of IRF3 in GRX-1 KD cells, suggesting that
S-glutathionylated IRF3 cannot interact with CBP.
Immunoprecipitation of CBP in nuclear extracts of control
and GRX-1 KD cells showed dramatically decreased amount
of co-precipitated IRF3 in virally induced GRX-1-underexpres-
sing cells, indicating that deglutathionylation of IRF3 is
needed for efficient interaction between CBP and the acti-
vated IRF3. The role of the deglutathionylation of IRF3 for its
interaction with CBP was also demonstrated by the increased
amount of IRF3 that was co-precipitated with CBP in virally
induced GRX-1 KD nuclear extracts pretreated with hGRX-1.
In addition, treatment of virally infected nuclear extracts with
DTT diminished the CBP-IRF3 co-precipitation, indicating a
requirement for thiol bonds for this interaction. Cysteines
participating in thiol bonds are crucial for the function of
IRF3 (Qin et al, 2003) and some of them might be protected
from non-reversible oxidation by being S-glutathionylated,
although the factor remains inactivated in the cytoplasm.
Sendai virus induction results in deglutathionylation of these
cysteines through GRX-1; thus, the activated IRF3 may
form the essential thiol bonds needed to establish interaction
with CBP.
The role of the cysteines in the transactivation ability of
IRF3 was investigated by transfection experiments using
mutant forms of IRF3 bearing cysteine-to-serine substitu-
tions. We constructed six single-point mutants, one for each
cysteine of the IRF3 molecule (C167S, C222S, C267S, C289S,
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C347S and C371S) and analysed the glutathionylation
status of these mutated proteins in immunoprecipitation
experiments from transfected TV7 cells. All of them were
S-glutathionylated, suggesting that there are more than one
glutathionylated cysteines in the molecule (data not shown).
We also tested their transactivation ability in transfection
experiments in TV7 and TGi14 cells. In TV7 cells, mutants
C164S and C267S have similar transactivation ability as the
wild-type IRF3. Mutation of cysteines 222 or 347 resulted in
25 and 30% lower activation, respectively. Mutation of
cysteines 289 and 371 resulted in 50% loss of the transactiva-
tion ability of the molecule, respectively (Supplementary
data, Supplementary Figure S4). These findings indicate
that more than one cysteine residues are involved in the
transactivation ability of IRF3, probably through a network of
thiol bonds. Therefore, these thiol bonds cannot be formed
when one or both of the participating cysteines are glutathio-
nylated. Interestingly, mutation of these cysteines could affect
not only their glutathionylation state but also their ability to
participate in disulphides with other cysteines in cis or trans.
Thus, elimination of a specific cysteine would not necessarily
result in hyperactivation of IRF3, but it could lower its
transactivation ability. Indeed, we found that some of these
mutations decreased the ability of IRF3 to activate transcrip-
tion. To identify the cysteines that are glutathionylated, we
immunoprecipitated IRF3 and subjected the protein to mass
spectrometry analysis. Despite our intense efforts, standard
MS methods failed to identify IRF3 (not shown) probably due
to lack of peptide ionization. We should point out that no
IRF3 MS identifications have been reported.
GRX-1 is constantly active and able to perform deglutathio-
nylation of S-glutathionylated proteins when modified
cysteines can be accessed by the enzyme (Supplementary
data, Supplementary Figure S1) (Fernandes and Holmgren,
2004; Ghezzi, 2005). Phosphorylation of IRF3, leading to
exposure of its transactivation domain, might also be the
critical event needed for GRX-1 to approach and deglutathio-
nylate the factor. Sendai virus does not induce GRX-1 expres-
sion, so we believe that it makes IRF3 available, as substrate
for GRX-1.
Inactive IRF3 constitutively shuttles in and out of the
nucleus, with its export signal more active than its NLS,
favouring the factor’s presence to the cytoplasm (Reich,
2002). We have shown that S-glutathionylation of IRF3
inhibits its transactivation ability, thus the modification
may also act as an extra ‘secure lock’ preventing any un-
necessary or random accidental activation of IRF3 and sub-
sequently of IFNb.
Collectively, our findings demonstrate a novel regulatory
role for GRX-1 in the IFNb pathway. We propose that IRF3 is
S-glutathionylated and upon viral infection it becomes deglu-
tathionylated by the action of GRX-1. This modification is
prerequested for IRF3, to associate with the CBP co-activator
and become fully transcriptionally active. Our findings
support, along with previous reports, an essential role of
S-glutathionylation as a crucial post-translational protein
modification mechanism that may control cell signal
pathways associated with viral infections.
Materials and methods
Plasmids
PRDII4–luc, PRDIII–I3-luc and –110-luc reporter plasmids were
constructed by subcloning four PRDII, seven PRDIII-I sites and
the IFNb promoter (1 to 110 bp upstream the initiation codon of
ifnb gene) respectively, to pGL3 basic vector (Promega). These
plasmids were used for assays of NF-kB, IRF and IFNb promoter
activation. GFP-IRF3 plasmid was constructed by cloning the entire
IRF3 ORF into the pEGFP-C2 mammalian expression vector (BD
Biosciences) and was used for IRF3 nuclear translocation assay.
pIRES–GRX-1 was constructed by cloning the entire ORF of GRX-1
into the pIRES-neo mammalian expression vector (CLONTECH) and
was used for GRX-1 overexpression. Plasmid GAL4-luc (5xGAL4-
TATA-luc) (Sun et al, 1994), GAL4–IRF3 DN133 (Senger et al, 2000),
GAL4–VP16 (White et al, 1992), IL-8 promoter-luc (Agelopoulos
and Thanos, 2006), pRSV–CBP (Merika et al, 1998) and pGK–b-gal
(Luftig et al, 2003) have been described. PCDNA3–Flag–DRF–
TRAF6 was kindly provided by G Mosialos (Aristotle University of
Thessaloniki, Greece). Vector pSuperior-puro siRNA system was
purchased from Oligo Engine and used for generating stable control
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Figure 9 GRX-1 underexpression affects the IRF3–CBP interaction.
(A) Immunoprecipitation of CBP from nuclear extracts (150mg) of
TV7 and TGi14 cells either mock-induced or induced with virus for
9 h. Proteins were separated on SDS–PAGE and probed with anti-
IRF3 and anti-CBP antibodies. (B) Immunoprecipitation of CBP from
nuclear extracts (300mg) untreated or pretreated with DTT (10 mM
for 15 min at 251C) of TGi14 cells either mock-induced or induced
with virus for 9 h. Proteins were western blotted with anti-IRF3 and
anti-CBP antibodies. (C) Immunoprecipitation of CBP from nuclear
extracts (300 mg) untreated or pretreated with hGRX-1 (400 mg ml1
for 15 min at 251C) of TGi14 cells either mock-induced or induced
with virus for 9 h. Proteins were western blotted with anti-IRF3 and
anti-CBP antibodies. (D) Immunoprecipitation of IRF3 from cyto-
plasmic extracts (300mg) untreated or pretreated with hGRX-1
(400mg ml1 for 15 min at 251C) of mock TV7 cells. Proteins were
western blotted with anti-IRF3 and anti-GSH antibodies.
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and siRNA cell lines. All constructs were verified by DNA
sequencing.
Cell cultures, transfections, viral infections, IFN b induction,
reporter gene and glutathione assays
HEK293 and HeLa cells (ATCC) were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma) supplemented with
10% heat-inactivated FBS (GIBCO/BRL), 2 mM L-glutamine (Sigma)
and 80 mg ml1 gentamycin (GIBCO/BRL). For BSO experiments,
cells were cultured for 4 days with 200 mM BSO (Sigma). For
transfection experiments 3105 cells per well onto 12-well culture
plates were transfected with LF 2000 (Invitrogen). After 4 h of
incubation, transfection mixture was replaced with culture med-
ium. Cell lysates were obtained 20–24 h post-transfection. Lucifer-
ase reporter assays were normalized for transfection efficiency by
co-transfection of b-galactosidase expression plasmid (pGK-b-gal).
b-gal activity values were measured with the Galacton-Plus
substrate system (Tropix, Bedford, MA). In experiments where
CBP was overexpressed, luciferase assays were normalized with the
amount of total protein of the samples, measured by Bradford
protein assay (Sigma).
For GFP-IRF3 nuclear translocation assays, cells were
transfected with 0.5 mg GFP-IRF3 and 18 h later were either
mock-infected or infected with Sendai virus. Sixteen hours post-
infection, living cells were observed under a fluorescent microscope
to determine the percentage of cells with GFP-IRF3 nuclear
translocation.
Viral infections were performed with 50 hemagglutinating
units ml1 culture media of Sendai virus (Cantell strain; Charles
River laboratories) for 9 or 16 h in antibiotic free medium.
Inductions with recombinant IFNb (ImmunoTools) were per-
formed with 500 IU ml1 in antibiotic free medium for 30 min.
Glutathione concentrations in TV7 and TGi14 cells were
measured according to Akerboom and Sies (1981).
siRNA
Stable siRNA cell lines were produced by the pSuperior-puro vector
system for inducible expression of siRNA (OligoEngine). The
following oligonucleotides encoding the desired siRNA strands for
GRX-1 mRNA were annealed and cloned to pSuperior-puro vector:
50-GTACCCCCCATCAAACAAGGGCTTCTTTCAAGAGAAGAAGCCCT
TGTTTGATGGGGC-30 (sense); 50-TCGAGCCCCATCAAACAAGGGC
TTCTTCTCTTGAAAGAAGCCCTTGTTTGATGGGGG-30 (anti-sense).
pSuperior-puro vector (control) or pSuperior-puro vector where
the oligonucleotide was cloned were transfected to HEK 293 or
HeLa cells. Forty-eight hours post-transfection, puromycin (Sigma)
was added to the cultures to a final concentration of 2mg ml1. After
7 days in puromycin, colonies of stably transfected cells were
collected. Control and stable siRNA lines were tested for GRX-1
expression with real-time PCR.
Immunoassays, western blot analysis and antibodies
Cells were washed with PBS (137 mM NaCl/3 mM KCl/6.5 mM
Na2HPO4/0.5 mM KH2PO4) (pH 7.4), collected by scraping and
centrifuged at 3000 g for 1 min. Cytoplasmic protein extracts were
prepared by fractionation of cells with a Dounce homogenizer
under hypotonic conditions (buffer A: 10 mM HEPES–KOH, pH 7.9,
1.5 mM MgCl2, 10 mM KCl, 1 mM Na3VO4, 0.5% Nonidet P-40,
1 mM phenylmethylsulphonyl fluoride (PMSF) and 1 protease
inhibitor mixture (Roche Diagnostics)). Nuclei were precipitated by
centrifugation at 12 000 g for 20 s at 41C. For nuclear protein extracts
preparation, sucrose was added to the lysates to a 0.25 M final
concentration and nuclei were precipitated by centrifugation
(1000 g) in a swing rotor. Nuclei pellet was resuspended in buffer
A with 0.25 M sucrose and precipitated again by centrifugation. The
pellet was washed five times with hypotonic buffer without sucrose,
resuspended in hypertonic buffer (buffer B: 25 mM HEPES (pH 7.9),
420 mM NaCl, 0.5% Nonidet P-40, 1.5 mM MgCl2, 1 mM Na3VO4,
2 mM PMSF and 1 protease inhibitor mixture) and incubated for
20 min under shaking at 41C. Insoluble material was removed by
centrifugation (12 000 g, 20 min, 41C). Protein yields were measured
with the Bradford protein assay kit. Whole-cell protein extracts
were prepared by heating cells suspended in 1 SDS-loading buffer
(Roth) at 1001C for 5 min.
For immunoprecipitation experiments, equal protein amounts of
cytoplasmic or nuclear extracts were incubated with protein
A-agarose beads (Gibco/BRL) crosslinked with pre-immune rabbit
or mouse serum for 2 h at 41C (pre-clear). Crosslinking of the beads
with the pre-immune serum was performed by DSS (Pierce)
according to the manufacturer’s protocol. Following pre-clearing,
extracts were incubated with an excess of antibody overnight at 41C
followed by incubation with protein A-agarose beads for 2 h at 41C,
washed with buffer A, suspended in 1 SDS buffer and heated for
5 min at 801C.
Proteins were separated by SDS–PAGE transferred to nitrocellu-
lose membranes (Protran) by wet transfer at 250 mA for 2–14 h at
41C. Membranes were blocked with 5% nonfat dry milk in PBS-
0.1%Tween-20 (PBST) at room temperature for 1 h. Native gel
electrophoresis and protein transfer to nitrocellulose membrane
were performed as described previously (Seth et al, 2005). Whole-
cell extracts for native gel electrophoresis were prepared by
combining cytoplasmic and nuclear extract preparations.
Treatment of nuclear extracts with DTT was carried out by
addition of freshly prepared DTT to 300mg virally induced TGi14
nuclear extracts to a final concentration of 10 mM. Extracts were
incubated at room temperature for 15 min and then used for
immunoprecipitation. Treatment of nuclear extracts with purified
hGRX-1 was carried out as follows: 300mg of virally induced TGi14
nuclear extracts were incubated at room temperature for 15 min
with 0.5 mM GSH (Sigma), 1.5 U glutathione reductase from bakers
yeast (Sigma), 400 mg ml1 NADPH (Sigma) with or without
400 mg ml1 hGRX-1 (IMCO, Sweden). Extracts were then subjected
to immunoprecipitation with CBP antibody.
Mouse Abs for GSH moieties on proteins (101-A, Virogen,
Watertown, MA), GRX-1 (ABNOVA), b-Actin (Sigma), GAPDH
(Chemicon) and Flag epitope (Santa Cruz) were used at 1:1000,
1:500, 1:5000, 1:2000 and 1:300 dilutions in PBST, respectively,
overnight at 41C. Rabbit polyclonal Abs for IRF3, STAT1 and CBP
(Santa Cruz) were used in 1:300 dilution in PBST for 3 h at room
temperature. Anti-rabbit and anti-mouse-HRP secondary antibodies
were from Jackson Immunoresearch Lab Inc.
Total RNA isolation, reverse transcription and real-time PCR
Total RNA was isolated from cells using Trizol reagent (Gibco BRL).
RNA quality was checked electrophoretically, and quantification
was done spectrophotometrically. RNA samples were treated with
DNAse (Promega). First-strand cDNAs were obtained by RT
reaction, performed with 2mg RNA, 50pmol random primer (6-mer),
10 mM dNTPs and 25 units of StrataScript Reverse Transcriptase
(Stratagene) at 421C for 1 h.
Quantitative real-time PCR (qRT–PCR) was performed using a
Chromo4 Real-Time System (Bio-Rad), selected gene primers, cDNA
template and Platinum Cyber Green qPCR Supermix UTG (Invitro-
gen, Carlsbad, CA) under the following conditions: 521C for 2 min,
951C for 5 min, followed by 40 cycles of 951C for 1 min, 581C for 35 s
and 721C for 5 s. Data were obtained using Opticon Monitor Version
3.1 software. All reactions were performed in triplicate, together
with blank (no template) controls. Melting curves for each PCR
reaction were generated to ensure the purity of the amplified
products. No primer dimers were detected when denaturation
curves performed. For normalization, respective GAPDH mRNA
quantities for each cDNA sample were measured. Changes in gene
expression level were calculated by the 2DDCt method (Livak and
Schmittgen, 2001). Data are presented as means7s.d. from a
minimum of three independent experiments.
The following primer pairs were used for qRT–PCR:
GRX-1 forward: CACAGCCACCAACCACACTA
GRX-1 backward: GCCGCGTCAGCAGTTCCCC
GRX-2 forward: CTTTGGAGAATTTAGCGACGGC
GRX-2 backward: CTGGTTTCCATATTCAAGCAGGT
IFNb forward: CACGACAGCTCTTTCCATGA
IFNb backward: AGCCAGTGCTCGATGAATCT
IL8 forward: TAGGACAAGAGCCAGGAAGAAAC
IL8 backward: GGAGTATGTCTTTATGCACTG
GAPDH forward: CATGAGAAGTATGACAACAGCCT
GAPDH backward: AGTCCTTCCACGATACCAAAGT
IRF3 DNA binding assay
Nuclear extracts from TV7 and TGi14 cells either mock-induced or
induced with Sendai virus for 4 h were prepared as described above.
Biotinylated-ISRE ds-oligo (Bio-ISRE) from the ISG15 promoter
(Biotin-CATGCCTCGGGAAAGGGAAACCGAAACTGAAGCC) (Lin et al,
1998) was incubated with equilibrated magnetic steptavidin beads
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(Dynal) in binding buffer A (1 M NaCl, 5 mM Tris–HCl pH 7.5,
0.5 mM EDTA pH 8.0) for 20 min under rotation at room
temperature. Equal protein amounts of extracts were not incubated
or pre-incubated in DNA binding buffer B (100 mM Tris–HCl pH 7.5,
10 mM EDTA pH 8.0, 50% glycerol, 2mg ml1 poly dI/dC) with
50 times more non-biotinylated ISRE ds-oligo (wt-ISRE)
(CATGCCTCGGGAAAGGGAAACCGAAACTGAAGCC) or non-bioti-
nylated ISRE mutated ds-oligo (Mut-ISRE) (GGCGGGATCGGGACA
CCGACACTGAA) for 10 min on ice.
Equal amount of streptavidin beads bound to Bio-ISRE was
added to all samples, but control sample where empty streptavidin
beads were added, and incubated at room temperature for 20 min.
Beads were washed five times with binding buffer B, diluted in 1
SDS-loading buffer, heated at 1001C for 5 min and subjected to SDS–
PAGE electrophoresis. Proteins were transferred to nitrocellulose
membrane and western blotted with anti-IRF3 and anti-GSH
antibodies.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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